She' has patients on the drug. That means she has CRAs visiting regularly for data review. They aren't privy to insider information, but they can learn things from the course of business. When Cytodyn bought Pro-140, they had someone audit the files. They had findings they wanted addressed. Progenics contacted me because I'd been on the study. I didn't know who was buying Pro-140, but I knew it was being sold.